CAR T cell immunotherapy, illustration

What can Kymriah® (tisagenlecleucel) offer in the treatment landscape of r/r follicular lymphoma?

This training has expired and can no longer be completed.

Course details

Valid until
14 Dec 2024
Course provider
Medical Tribune (MedTriX AG), Grosspeterstrasse 23, 4052 Basel
Location of course
online
We are able to realize this webinar thanks to the kind support of Novartis.
Novartis Logo